AllianceBernstein’s RAPT Therapeutics RAPT Stock Holding History

AllianceBernstein’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,339	Closed	-$61.9K	–	3312
2025 Q1	$61.9K	Hold	6,339	–	–	﹤0.01%	3112
2024 Q4	$80.1K	Hold	6,339	–	–	﹤0.01%	3145
2024 Q3	$102K	Hold	6,339	–	–	﹤0.01%	3131
2024 Q2	$155K	Buy	6,339 +2,476	+64%	+$114K	﹤0.01%	3068
2024 Q1	$277K	Hold	3,863	–	–	﹤0.01%	2832
2023 Q4	$768K	Hold	3,863	–	–	﹤0.01%	2402
2023 Q3	$514K	Hold	3,863	–	–	﹤0.01%	2555
2023 Q2	$578K	Hold	3,863	–	–	﹤0.01%	2557
2023 Q1	$567K	Hold	3,863	–	–	﹤0.01%	2507
2022 Q4	$612K	Buy	3,863 +350	+10%	+$56K	﹤0.01%	2523
2022 Q3	$676K	Hold	3,513	–	–	﹤0.01%	2498
2022 Q2	$513K	Hold	3,513	–	–	﹤0.01%	2674
2022 Q1	$618K	Buy	3,513 +13	+0.4%	+$2.46K	﹤0.01%	2592
2021 Q4	$1.03M	Hold	3,500	–	–	﹤0.01%	2456
2021 Q3	$869K	Hold	3,500	–	–	﹤0.01%	2544
2021 Q2	$890K	Buy	3,500 +1,675	+92%	+$313K	﹤0.01%	2585
2021 Q1	$324K	Hold	1,825	–	–	﹤0.01%	2865
2020 Q4	$288K	Hold	1,825	–	–	﹤0.01%	2877
2020 Q3	$470K	Buy	1,825 +175	+11%	+$38.8K	﹤0.01%	2557
2020 Q2	$383K	Buy	+1,650	New	+$255K	﹤0.01%	2770

Other funds holding RAPT

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

FCMV

Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

AllianceBernstein's RAPT Position: Q2 2025 in Review

AllianceBernstein sold out of RAPT Therapeutics (RAPT) in Q2 2025, closing a stake of 6,339 shares — an estimated $61.9K sold.

AllianceBernstein first reported a position in RAPT in Q2 2020 and held it in 20 quarters. The position peaked at $1.03M in Q4 2021. 50 funds tracked by Wall St. Rank hold RAPT as of Q2 2025.

AllianceBernstein reported no remaining RAPT Therapeutics position as of Q2 2025 after selling out during the quarter.
AllianceBernstein sold 6,339 RAPT Therapeutics shares in Q2 2025, an estimated $61.9K.
AllianceBernstein first reported a position in RAPT Therapeutics in Q2 2020 and held it in 20 quarters.
AllianceBernstein's RAPT Therapeutics position peaked at $1.03M in Q4 2021.
50 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.